West Bengal minister Firhad Hakim, who volunteered for the section-3 trial of Covid-19 vaccine Covaxin, was administered the second dose on Wednesday.
Hakim was administered the primary dose on December 2 when the trial kick-began in Kolkata. He was the primary volunteer in Kolkata.
Governor Jagdeep Dhankhar, who launched the trial, had additionally expressed his curiosity to volunteer. Doctors, nevertheless, stated that he had some co-morbidities.
Also learn: Bars, restaurants to restrict entry, limited parking at Connaught Place
Kolkata’s National Institute of Cholera and Enteric Diseases (ICMR-NICED) was one of the institutes chosen to conduct the Central Drugs Standard Control Organisation-approved regulatory trials.
“The volunteer’s health parameters would be monitored over the next two weeks and he has to undergo some tests,” stated a NICED official.
The outcomes of the section-3 trial of Covaxin can be out there in November 2021, ICMR-NICED officers stated. An interim report could also be out there by May 2021.
West Bengal minister Firhad Hakim grew to become the first volunteer for the phase-3 trial of Covid-19 vaccine Covaxin, which was launched in Kolkata on Wednesday.
“I am quite lucky to be part of the trial. I am absolutely fine. I do not care even if I die while undertaking this trial,” Hakim mentioned.
Governor Jagdeep Dhankhar, who launched the trial, has additionally expressed his curiosity to volunteer.
Covaxin, the first indigenously-developed Covid-19 vaccine, is being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Also learn | Vaccines won’t prevent short-term coronavirus surge: WHO
Kolkata’s National Institute of Cholera and Enteric Diseases (ICMR-NICED) is one of the institutes chosen to conduct the Central Drugs Standard Control Organisation-approved regulatory trials.
The outcomes of the phase-3 trial of Covaxin shall be accessible in November 2021, ICMR-NICED officers mentioned. An interim report could also be accessible by May 2021.
“The analysis will take a year. An interim analysis may be done after six months. If it is found that the vaccine has sufficient protective efficacy, the results would be shared with the policymakers. The government will take the final call thereafter,” mentioned Shanta Dutta, director of NICED.
West Bengal’s Urban Development Minister Firhad Hakim grew to become the second minister of a state authorities within the nation to be administered a shot of Covaxin, India’s first indigenous COVID-19 vaccine candidate whose Phase III trial started right here on Wednesday.
The trial, which began on the metropolis’s ICMR-National Institute of Cholera and Enteric Diseases (NICED), was inaugurated by state Governor Jagdeep Dhankhar.
“I feel I am quite lucky to be part of the trial. I am absolutely okay after taking the shot. I do not care even if I die while undertaking this trial,” the 62-12 months-previous minister instructed reporters.
Hakim mentioned that he shall be very glad if his contribution helps within the quest for the vaccine in opposition to the coronavirus illness.
Hakim underwent vital verify-ups to confirm whether or not he was match for the shot.
At least 1,000 volunteers shall be administered the vaccine through the Phase III trial right here.
Before him, Haryana’s Health Minister Anil Vij was administered a dose of Covaxin final month as a part of the Phase III scientific trial .